The investment seeks growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPXX | 19.08 | 0.09 | +0.47% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| FBDC | 17.67 | N/A | -0.01% |
| FT Confluence BDC & SpecialtyFinacIncETF | |||
| CALI | 50.38 | -0.01 | -0.03% |
| iShares Short-Term CA Muni Act ETF | |||
| WEA | 10.43 | -0.05 | -0.48% |
| Western Asset Premier | |||
| BIS | 10.82 | -0.30 | -2.70% |
| ProShares UltraShort Nasdaq Biotech | |||
A.I.dvisor indicates that over the last year, NBMBX has been closely correlated with FSMAX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NBMBX jumps, then FSMAX could also see price increases.
| Ticker / NAME | Correlation To NBMBX | 1D Price Change % | ||
|---|---|---|---|---|
| NBMBX | 100% | +0.99% | ||
| FSMAX - NBMBX | 93% Closely correlated | N/A | ||
| PEMGX - NBMBX | 83% Closely correlated | +0.82% | ||
| PMBJX - NBMBX | 77% Closely correlated | +0.81% | ||
| JDMAX - NBMBX | 70% Closely correlated | N/A | ||
| JDMRX - NBMBX | 69% Closely correlated | N/A | ||
More | ||||